Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41122 Modena, Italy.
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, 41122 Modena, Italy.
Cells. 2023 Sep 8;12(18):2236. doi: 10.3390/cells12182236.
Testis stimulation with follicle-stimulating hormone (FSH) is one of the empirical treatments proposed for male idiopathic infertility, although reliable markers to predict its efficacy are still lacking. This study aimed to identify parameters able to predict FSH efficacy in terms of pregnancy achievement. A real-world study was conducted, enrolling idiopathic infertile men treated with FSH 150IU three times weekly. Patients were treated until pregnancy achievement or for a maximum of two years and two visits were considered: V0 (baseline) and V1 (end of FSH treatment). Primary endpoints were the V1-V0 percentage change in sperm concentration, total sperm count, and total motile sperm number. In total, 48 pregnancies were recorded (27.7%) among 173 men (age 37.9 ± 6.2 years). All three endpoints increased after FSH administration, and only the V1-V0 percentage of sperm concentration significantly predicted pregnancy ( = 0.007). A V1-V0 sperm concentration of 30.8% predicted pregnancy, and the sperm concentration V1-V0 percentage (Y) required to obtain a pregnancy was predicted according to its baseline values (x): Y = 9.8433x - 203.67x + 958.29. A higher number of pregnancies was reached in men with baseline sperm concentration below 7.3 million/mL. Thus, the percentage of sperm concentration increasing after FSH administration could predict the treatment efficacy in terms of pregnancy. At the dosage used, the efficacy was significantly higher in patients with a starting sperm concentration < 7.3 mill/mL. Mathematical analyses identified a function able to predict the sperm concentration increase required to obtain a pregnancy in relation to the baseline sperm number.
睾丸刺激用卵泡刺激素(FSH)是治疗男性特发性不育的经验性治疗方法之一,尽管仍缺乏可靠的预测其疗效的标志物。本研究旨在确定能够预测 FSH 治疗妊娠效果的参数。进行了一项真实世界研究,纳入接受 FSH 150IU 每周三次治疗的特发性不育男性患者。患者接受治疗直至妊娠或最多治疗两年和两次就诊:V0(基线)和 V1(FSH 治疗结束)。主要终点是精子浓度、总精子数和总活动精子数的 V1-V0 百分比变化。在 173 名男性中(年龄 37.9 ± 6.2 岁),共记录到 48 例妊娠(27.7%)。FSH 给药后所有三个终点均增加,只有精子浓度的 V1-V0 百分比显著预测妊娠(= 0.007)。V1-V0 精子浓度为 30.8%预测妊娠,并且根据其基础值(x)预测获得妊娠所需的精子浓度 V1-V0 百分比(Y):Y = 9.8433x - 203.67x + 958.29。基线精子浓度低于 7.3 百万/mL 的男性达到妊娠的数量更高。因此,FSH 给药后精子浓度的增加百分比可以预测妊娠方面的治疗效果。在使用的剂量下,起始精子浓度<7.3 百万/mL 的患者疗效明显更高。数学分析确定了一个能够预测与基础精子数相关的妊娠所需的精子浓度增加的函数。